Literature DB >> 29336263

In vitro Methods for In vitro-In vivo Correlation (IVIVC) for Poorly Water Soluble Drugs: Lipid Based Formulation Perspective.

Mohsin Kazi1, Rayan Al Amri1, Fars K Alanazi1, Muhammad Delwar Hussain2.   

Abstract

A great number of new drug candidates identified from the discovery pipeline are poorly water soluble, which is a drawback to bring such candidates into the pharmaceutical market. Formulating these compounds as self-emulsifying/microemulsifying/ nanoemulsifying drug delivery systems (SEDDS/SMEDDS/SNEDDS) within lipid based formulations is of growing interest. Some of the recent studies have resulted in commercial products that provided improved bioavailability and dissolution due to the better dispersion properties of SEDDS/SMEDDS/SNEDDS. An ongoing challenge that the pharmaceutical industry is facing is identifying in vitro tests that are needed in order to predict the behavior of dosage forms in the GI tract. The goal of the current review is to present the various levels of in vitro-in vivo correlations (IVIVCs) and to provide tools on the utilization of the IVIVCs in product development and optimization of SEDDS/SMEDDS/SNEDDS. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  IVIVC; Lipid based formulation; SEDDS/SMEDDS/SNEDDS; dissolution; lipolysis; poorly water soluble drugs.

Mesh:

Substances:

Year:  2018        PMID: 29336263     DOI: 10.2174/1567201815666180116090910

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  3 in total

1.  Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.

Authors:  Yufeng Zhang; Hua Liu; Minghui Johnson Tang; Nicolas James Ho; Tsun Lam Shek; Zhijun Yang; Zhong Zuo
Journal:  AAPS J       Date:  2021-03-04       Impact factor: 4.009

2.  Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate.

Authors:  Hayley B Schultz; Paul Joyce; Nicky Thomas; Clive A Prestidge
Journal:  Pharm Res       Date:  2020-03-31       Impact factor: 4.200

3.  Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus.

Authors:  Mohsin Kazi; Abdulmohsen Alqahtani; Ajaz Ahmad; Omar M Noman; Mohammed S Aldughaim; Ali S Alqahtani; Fars K Alanazi
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.